CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.
Berkhout TA, Blaney FE, Bridges AM, Cooper DG, Forbes IT, Gribble AD, Groot PH, Hardy A, Ife RJ, Kaur R, Moores KE, Shillito H, Willetts J, Witherington J.
Berkhout TA, et al. Among authors: groot ph.
J Med Chem. 2003 Sep 11;46(19):4070-86. doi: 10.1021/jm030862l.
J Med Chem. 2003.
PMID: 12954060